Contact Us

Service Line:+1-315-239-3085

Address:FL-4, Building A5, International Enterprise Community, Tianjin, China

Email:info@kmdbioscience.com

Online Inquery

  •   
  •   
  •   
  • Refresh

Anti-Human CD19 & CD3E Recombinant Antibody(Blinatumomab)

Product Information
Catalog Number YR1047
Product Name Anti-Human CD19 & CD3E Recombinant Antibody(Blinatumomab)
Molecular Name Blinatumomab
Alias Anti-CD19 & CD3E Recombinant Antibody, Research Grade Blinatumomab
CAS Number 853426-35-4
Molecular Weight 54.1 kDa
Target CD19 & CD3E[Homo sapiens]
Isotype (scFv Kappa-heavy)-(scFv-heavy Kappa)
Clonity Monoclonal
Source CHO Cells
Size 1mg, 5mg
Concentration 1mg/ml
Purity >95% as determined by SDS-PAGE
Buffer PBS, pH7.5
Background Blinatumomab, sold under the brand name Blincyto, is a biopharmaceutical medication used as a second-line treatment for Philadelphia chromosome-negative relapsed or refractory acute lymphoblastic leukemia.
Storage It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note This product is for research use only.